Crescita Therapeutics Inc.
CRRTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $19,580 | $17,522 | $23,525 | $16,769 |
| % Growth | 11.7% | -25.5% | 40.3% | – |
| Cost of Goods Sold | $9,972 | $7,158 | $10,343 | $6,755 |
| Gross Profit | $9,608 | $10,364 | $13,182 | $10,014 |
| % Margin | 49.1% | 59.1% | 56% | 59.7% |
| R&D Expenses | $646 | $699 | $609 | $634 |
| G&A Expenses | $10,811 | $10,115 | $0 | $0 |
| SG&A Expenses | $10,811 | $10,115 | $10,573 | $8,720 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,366 | $1,506 | $0 | $0 |
| Operating Expenses | $12,823 | $12,320 | $12,653 | $10,733 |
| Operating Income | -$3,215 | -$1,956 | $529 | -$719 |
| % Margin | -16.4% | -11.2% | 2.2% | -4.3% |
| Other Income/Exp. Net | $451 | $426 | -$125 | -$290 |
| Pre-Tax Income | -$2,764 | -$1,530 | $404 | -$1,009 |
| Tax Expense | -$14 | $456 | -$458 | $96 |
| Net Income | -$2,750 | -$1,986 | $862 | -$1,105 |
| % Margin | -14% | -11.3% | 3.7% | -6.6% |
| EPS | -0.14 | -0.1 | 0.042 | -0.053 |
| % Growth | -40% | -339.8% | 178.4% | – |
| EPS Diluted | -0.14 | -0.098 | 0.041 | -0.053 |
| Weighted Avg Shares Out | 19,272 | 19,860 | 20,691 | 20,755 |
| Weighted Avg Shares Out Dil | 19,272 | 20,255 | 21,000 | 20,755 |
| Supplemental Information | – | – | – | – |
| Interest Income | $496 | $507 | $260 | $182 |
| Interest Expense | $65 | $85 | $158 | $236 |
| Depreciation & Amortization | $1,366 | $1,506 | $1,471 | $1,379 |
| EBITDA | -$1,333 | -$450 | $2,000 | $606 |
| % Margin | -6.8% | -2.6% | 8.5% | 3.6% |